Cytokines and neuro-immune-endocrine interactions: A role for the hypothalamic-pituitary-adrenal revolving axis

Journal of Neuroimmunology

Volumn 133, Issue 1-2, 2002, Pages 1-19

  Haddad, John J ^a   Saadé, Nayef E ^b   Safieh Garabedian, Bared ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Brain; CNS; Cytokine; HPA; Inflammation; Neuroimmunology; Neuropeptide; Neurotransmitters; Oxidative stress; Transcription

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MARKER; NEUROTRANSMITTER; PEPTIDE HORMONE; RECEPTOR;

BRAIN; ENDOCRINE SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNITY; IMMUNOREGULATION; INFECTION; NERVOUS SYSTEM; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; NEUROTRANSMISSION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STIMULATION; STRESS; TRANSCRIPTION REGULATION;

ANIMALS; CYTOKINES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROIMMUNOMODULATION; NEUROSECRETORY SYSTEMS; NITRIC OXIDE; OXIDATIVE STRESS; PITUITARY-ADRENAL SYSTEM;

EID: 0036889766     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00357-0     Document Type: Review

References (138)

1. Anforth H.R., Bluthe R.M., Bristow A., Hopkins S., Lenczowski M.J., Luheshi G., Lundkvist J., Michaud B., Mistry Y., Van Dam A.M., Zhen C., Dantzer R., Poole S., Rothwell N.J., Tilders F.J., Wollman E.E. Biological activity and brain actions of recombinant rat interleukin-1α and interleukin-1β Eur. Cytokine Netw. 9:1998;279-288.
2. Barna I., Acs Z., Bugovics G., Koenig J.I. Effect of interleukin-1β on plasma ACTH, β-endorphin and corticosterone levels in infant and prepubertal rats. Pediatr. Res. 37:1995;714-719.
3. Betancur C., Lledo A., Borrell J., Guaza C. Corticosteroid regulation of IL-1 receptors in the mouse hippocampus: effects of glucocorticoid treatment, stress and adrenalectomy. Neuroendocrinology. 59:1994;120-128.
4. Betancur C., Borrell J., Guaza C. Cytokine regulation of corticosteroid receptors in the rat hippocampus: effects of interleukin-1, interleukin-6, tumor necrosis factor and lipopolysaccharide. Neuroendocrinology. 62:1995;47-54.
5. Boraschi D., Cifone M.G., Falk W., Flad H.D., Tagliabue A., Martin M.U. Cytokines in inflammation. Eur. Cytokine Netw. 9:1998;205-212.
6. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 405:2000;458-462.
7. Boyle M., Yamamoto G., Chen M., Rivier J., Vale W. Interleukin 1 prevents loss of corticotropic responsiveness to β-adrenergic stimulation in vitro. Proc. Natl. Acad. Sci. U. S. A. 85:1988;5556-5560.
8. Brann D.W., Bhat G.K., Lamar C.A. Mahesh VB. Gaseous transmitters and neuroendocrine regulation. Neuroendocrinology. 65:1997;385-395.
9. Brown R., Li Z., Vriend C.Y., Nirula R., Janz L., Falk J., Nance D.M., Dyck D.G., Greenberg A.H. Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1β: evidence for pituitary-adrenal and sympathetic control. Cell. Immunol. 132:1991;84-93.
10. Brunetti L., Preziosi P., Ragazzoni E., Vacca M. Effects of lipopolysaccharide on hypothalamic-pituitary-adrenal axis in vitro. Life Sci. 54:1994;PL165-PL171.
11. Bugajski J. Role of prostaglandins in the stimulation of the hypothalamic-pituitary-adrenal axis by adrenergic and neuro-hormone systems. J. Physiol. Pharmacol. 47:1996;559-575.
12. Bugajski J., Gadek-Michalska A., Olowska A., Borycz J., Glod R. Role of nitric oxide in the vasopressin-induced corticosterone secretion in rats. J. Physiol. Pharmacol. 48:1997;805-812.
13. Buller K.M., Xu Y., Day T.A. Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β J. Neuroendocrinol. 10:1998;519-528.
14. Buller K., Xu Y., Dayas C., Day T. Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1β-induced hypothalamic pituitary adrenal axis responses. Neuroendocrinology. 73:2001;129-138.
15. Bumiller A., Gotz F., Rohde W., Dorner G. Effects of repeated injections of interleukin 1β or lipopolysaccharide on the HPA axis in the newborn rat. Cytokine. 11:1999;225-230.
16. Cambronero J.C., Rivas F.J., Borrell J., Guaza C. Release of corticotropin-releasing factor from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism. Eur. J. Pharmacol. 219:1992;75-80.
17. Cambronero J.C., Rivas F.J., Borrell J., Guaza C. Adrenalectomy does not change CRF secretion induced by interleukin-1 from rat perifused hypothalami. Regulatory Pept. 41:1992;237-247.
18. Chesnokova V., Melmed S. Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology. 143:2002;1571-1574.
19. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioral, neuro-chemical, endocrine and immune parameters in the rat. Neuroscience. 84:1998;923-933.
20. Cunningham E.T. Jr., De Souza E.B. Interleukin 1 receptors in the brain and endocrine tissues. Immunol. Today. 14:1993;171-176.
21. Cunningham E.T. Jr., Wada E., Carter D.B., Tracey D.E., Battey J.F., De Souza E.B. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J. Neurosci. 12:1992;1101-1114.
22. Das U.N. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot. Essent. Fat. Acids. 63:2000;351-362.
23. Daun J.M., Ball R.W., Cannon J.G. Glucocorticoid sensitivity of interleukin-1 agonist and antagonist secretion: the effects of age and gender. Am. J. Physiol., Regul. Integr. Comp. Physiol. 278:2000;R855-R862.
24. del Rey A., Klusman I., Besedovsky H.O. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1. Am. J. Physiol. 275:1998;R1146-R1151.
25. Dinarello C.A. Pro-inflammatory cytokines. Chest. 118:2000;503-508.
26. Dowdell K.C., Gienapp I.E., Stuckman S., Wardrop R.M., Whitacre C.C. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic-pituitary-adrenal axis. J. Neuroimmunol. 100:1999;243-251.
27. Dunn A.J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci. 43:1988;429-435.
28. Dunn A.J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmacol. Exp. Ther. 261:1992;964-969.
29. Dunn A.J., Chuluyan H.E. The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection. Life Sci. 51:1992;219-225.
30. Ebisui O., Fukata J., Murakami N., Kobayashi H., Segawa H., Muro S., Hanaoka I., Naito Y., Masui Y., Ohmoto Y. Effect of IL-1 receptor antagonist and antiserum to TNF-α on LPS-induced plasma ACTH and corticosterone rise in rats. Am. J. Physiol. 266:1994;E986-E992.
31. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve, an integrative interface between two super-systems: the brain and the immune system. Pharmacol. Rev. 52:2000;595-638.
32. Exton M.S., Bull D.F., King M.G., Husband A.J. Paradoxical conditioning of the plasma copper and corticosterone responses to bacterial endotoxin. Pharmacol. Biochem. Behav. 52:1995;347-354.
33. Fleshner M., Goehler L.E., Hermann J., Relton J.K., Maier S.F., Watkins L.R. Interleukin-1β induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res. Bull. 37:1995;605-610.
34. Franchimont D., Galon J., Gadina M., Visconti R., Zhou Y., Aringer M., Frucht D.M., Chrousos G.P., O'Shea J.J. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat-4 phosphorylation in T lymphocytes. J. Immunol. 164:2000;1768-1774.
35. Goujon E., Laye S., Parnet P., Dantzer R. Regulation of cytokine gene expression in the central nervous system by glucocorticoids: mechanisms and functional consequences. Psychoneuroendocrinology. 22:1997;S75-S80.
36. Grinevich V., Ma X.M., Herman J.P., Jezova D., Akmayev I., Aguilera G. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats. J. Neuroendocrinol. 13:2001;711-723.
37. Gwosdow A.R., Kumar M.S., Bode H.H. Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis. Am. J. Physiol. 258:1990;E65-E70.
38. Gwosdow A.R., O'Connell N.A., Spencer J.A., Kumar M.S., Aggarwal R.K., Bode H.H., Abou-Samra A.B. Interleukin-1-induced corticosterone release occurs by an adrenergic mechanism from rat adrenal gland. Am. J. Physiol. 263:1992;E461-E466.
39. Habu S., Watanobe H., Yasujima M., Suda T. Different roles of brain interleukin 1 in the adrenocorticotropin response to central versus peripheral administration of lipopolysaccharide in the rat. Cytokine. 10:1998;390-394.
40. Haddad J.J. Glutathione depletion is associated with augmenting a pro-inflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. Cytokines Cell. Mol. Ther. 6:2000;177-187.
41. p38-dependent regulation of pro-inflammatory cytokine production. Biochem. Pharmacol. 63:2002;305-320.
42. Haddad J.J., Fahlman C.S. Redox- and oxidant-mediated regulation of interleukin-10: an anti-inflammatory, antioxidant cytokine? Biochem. Biophys. Res. Commun. 297:2002;163-176.
43. 2-evoked regulation of HIF-1α and NF-κB in perinatal lung epithelium requires glutathione biosynthesis. Am. J. Physiol., Lung Cell. Mol. Physiol. 278:2000;L492-L503.
44. Haddad J.J., Land S.C. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-κB (RelA)-selective targeting. Biochem. Biophys. Res. Commun. 271:2000;257-267.
45. Haddad J.J., Land S.C. Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-α biosynthesis. Br. J. Pharmacol. 135:2002;520-536.
46. Haddad J.J., Land S.C. Amiloride blockades lipopolysaccharide-induced cytokine biosynthesis in an IκB-α/NF-κB-dependent mechanism: evidence for the amplification of an anti-inflammatory pathway in the alveolar epithelium. Am. J. Respir. Cell Mol. Biol. 26:2002;114-126.
47. Haddad J.J., Olver R.E., Land S.C. Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity: evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J. Biol. Chem. 275:2000;21130-21139.
48. 2/ROS) dependent release of IL-1β, IL-6 and TNF-α: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium. Cytokine. 13:2001;138-147.
49. Haddad J.J., Safieh-Garabedian B., Saadé N.E., Land S.C. Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium. J. Pharmacol. Exp. Ther. 296:2001;996-1005.
50. 193-195 receptor antagonism in the alveolar epithelium. Biochem. J. 355:2001;29-38.
51. Haddad J.J., Land S.C., Tarnow-Mordi W.O., Zembala M., KowaLczyk D., Lauterbach R. Immunopharmacological potential of selective phosphodiesterase inhibition: I. Differential regulation of lipopolysaccharide-mediated pro-inflammatory cytokine (interleukin-6 and tumor necrosis factor-α) biosynthesis in alveolar epithelial cells. J. Pharmacol. Exp. Ther. 300:2002;559-566.
52. Haddad J.J., Land S.C., Tarnow-Mordi W.O., Zembala M., KowaLczyk D., Lauterbach R. Immunopharmacological potential of selective phosphodiesterase inhibition: II. Evidence for the involvement of an inhibitory-κB/nuclear factor-κB-sensitive pathway in alveolar epithelial cells. J. Pharmacol. Exp. Ther. 300:2002;567-576.
53. Haddad J.J., Saadé N.E., Safieh-Garabedian B. Redox regulation of TNF-α biosynthesis: augmentation by irreversible inhibition of γ-glutamylcysteine synthetase and the involvement of an IκB-α/NF-κB-independent pathway in alveolar epithelial cells. Cell. Signal. 14:2002;211-218.
54. Hall N.R., McGillis J.P., Spangelo B.L., Goldstein A.L. Evidence that thymosins and other biologic response modifiers can function as neuro-active immunotransmitters. J. Immunol. 135:1985;806S-811S.
55. Hanisch U.K., Rowe W., Sharma S., Meaney M.J., Quirion R. Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2. Endocrinology. 135:1994;2465-2472.
56. Hermus A.R., Sweep C.G. Cytokines and the hypothalamic-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 37:1990;867-871.
57. Hillhouse E.W. Interleukin-2 stimulates the secretion of arginine vasopressin but not corticotropin-releasing hormone from rat hypothalamic cells in vitro. Brain Res. 650:1994;323-325.
58. Holloway A.F., Rao S., Shannon M.F. Regulation of cytokine gene transcription in the immune system. Mol. Immunol. 38:2002;567-580.
59. Hosoi T., Okuma Y., Nomura Y. Electrical stimulation of afferent vagus nerve induces IL-1β expression in the brain and activates HPA axis. Am. J. Physiol., Regul. Integr. Comp. Physiol. 279:2000;R141-R147.
60. Janowsky D.S., Risch S.C., Huey L.Y., Judd L.L., Rausch J.L. Hypothalamic-pituitary-adrenal regulation, neurotransmitters and affective disorders. Peptides. 4:1983;775-784.
61. Jones T.H., Kennedy R.L. Cytokines and hypothalamic-pituitary function. Cytokine. 5:1993;531-538.
62. Kakucska I., Qi Y., Clark B.D., Lechan R.M. Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology. 133:1993;815-821.
63. Kanaan S.A., Saadé N.E., Haddad J.J., Abdelnoor A.M., Atweh S.F., Jabbur S.J., Safieh-Garabedian B. Endotoxin-induced local inflammation and hyperalgesia in rats and mice: a new model for inflammatory pain. Pain. 66:1996;373-379.
64. Kanaan S.A., Safieh-Garabedian B., Haddad J.J., Atweh S.F., Abdelnoor A.M., Jabbur S.J., Saadé N.E. Effects of various analgesic and anti-inflammatory drugs on endotoxin-induced hyperalgesia in rats and mice. Pharmacology. 54:1997;285-297.
65. Kapcala L.P., Chautard T., Eskay R.L. The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious and inflammatory stress. Ann. N.Y. Acad. Sci. 771:1995;419-437.
66. Kim C.K., Rivier C. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. J. Neuroendocrinol. 10:1998;353-362.
67. Kim C.K., Rivier C.L. Nitric oxide and carbon monoxide have a stimulatory role in the hypothalamic-pituitary-adrenal response to physico-emotional stressors in rats. Endocrinology. 141:2000;2244-2253.
68. Kishimoto J., Tsuchiya T., Emson P.C., Nakayama Y. Immobilization-induced stress activates neuronal nitric oxide synthase (nNOS) mRNA and protein in hypothalamic-pituitary-adrenal axis in rats. Brain Res. 720:1996;159-171.
69. Lee S., Kim C.K., Rivier C. Nitric oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat. J. Neurosci. 19:1999;7640-7647.
70. Lezoualc'h F., Engert S., Berning B., Behl C. Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloidβ precursor protein and with the suppression of nuclear factor-κB. Mol. Endocrinol. 14:2000;147-159.
71. Liege S., Moze E., Kelley K.W., Parnet P., Neveu P.J. Activation of the hypothalamic-pituitary-adrenal axis in IL-1β-converting enzyme-deficient mice. Neuroimmunomodulation. 7:2000;189-194.
72. Lohrer P., Gloddek J., Nagashima A.C., Korali Z., Hopfner U., Pereda M.P., Arzt E., Stalla G.K., Renner U. Lipopolysaccharide directly stimulates the intrapituitary interleukin-6 production by folliculostellate cells via specific receptors and the p38α mitogen-activated protein kinase/nuclear factor-κB pathway. Endocrinology. 141:2000;4457-4465.
73. Lumry W.R. A review of the pre-clinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis. J. Allergy Clin. Immunol. 104:1999;S150-S158.
74. Ma X.C., Chen L.T., Oliver J., Horvath E., Phelps C.P. Cytokine and adrenal axis responses to endotoxin. Brain Res. 861:2000;135-142.
75. Makino Y., Okamoto K., Yoshikawa N., Aoshima M., Hirota K., Yodoi J., Umesono K., Makino I., Tanaka H. Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J. Clin. Invest. 98:1996;2469-2477.
76. Mastorakos G., Chrousos G.P., Weber J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 77:1993;1690-1694.
77. Mastorakos G., Weber J.S., Magiakou M.A., Gunn H., Chrousos G.P. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J. Clin. Endocrinol. Metab. 79:1994;934-939.
78. Michl P., Beikler T., Engelhardt D., Weber M.M. Interleukin-3 and interleukin-6 stimulate bovine adrenal cortisol secretion through different pathways. J. Neuroendocrinol. 12:2000;23-28.
79. Nelson R.J., Kriegsfeld L.J., Dawson V.L., Dawson T.M. Effects of nitric oxide on neuroendocrine function and behavior. Front. Neuroendocrinol. 18:1997;463-491.
80. Nukina H., Sudo N., Komaki G., Yu X., Mine K., Kubo C. The restraint stress-induced elevation in plasma interleukin-6 negatively regulates the plasma TNF-α level. Neuroimmunomodulation. 5:1998;323-327.
81. Okada S., Murakami Y., Yokotani K. Centrally applied nitric oxide donor elevates plasma corticosterone by activation of the hypothalamic noradrenergic neurons in rats. Brain Res. 939:2002;26-33.
82. Oppenheim J.J. Cytokines: past, present and future. Int. J. Hematol. 74:2001;3-8.
83. Paez Pereda M., Sauer J., Perez Castro C., Finkielman S., Stalla G.K., Holsboer F., Arzt E. Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology. 136:1995;5504-5510.
84. Paez Pereda M., Perez Castro C., Costas M., Nahmod V.E., Stalla G.K., Holsboer F., Arzt E. Glucocorticoids inhibit the auto-regulatory induction of interleukin-1 in monocytes after endotoxin stimulation. Neuroimmunomodulation. 3:1996;227-232.
85. Papadopoulos A.D., Wardlaw S.L. Endogenous α-MSH modulates the hypothalamic-pituitary-adrenal response to the cytokine interleukin-1β J. Neuroendocrinol. 11:1999;315-319.
86. Pariante C.M., Pearce B.D., Pisell T.L., Sanchez C.I., Po C., Su C., Miller A.H. The proinflammatory cytokine, interleukin-1α, reduces glucocorticoid receptor translocation and function. Endocrinology. 140:1999;4359-4366.
87. Parsadaniantz S.M., Lebeau A., Duval P., Grimaldi B., Terlain B., Kerdelhue B. Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1β in the male rat. J. Neuroendocrinol. 12:2000;766-773.
88. Payne L.C., Weigent D.A., Blalock J.E. Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone. Biochem. Biophys. Res. Commun. 198:1994;480-484.
89. Pedersen W.A., McCullers D., Culmsee C., Haughey N.J., Herman J.P., Mattson M.P. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 8:2001;492-503.
90. Perlstein R.S., Mougey E.H., Jackson W.E., Neta R. Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphokine Cytokine Res. 10:1991;141-146.
91. Perlstein R.S., Whitnall M.H., Abrams J.S., Mougey E.H., Neta R. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology. 132:1993;946-952.
92. Perlstein R.S., Mehta N.R., Mougey E.H., Neta R., Whitnall M.H. Systemically administered histamine H1 and H2 receptor antagonists do not block the ACTH response to bacterial lipopolysaccharide and interleukin-1. Neuroendocrinology. 60:1994;418-425.
93. Plagemann A., Staudt A., Gotz F., Malz U., Rohde W., Rake A., Dorner G. Long-term effects of early postnatally administered interleukin-1β on the hypothalamic-pituitary-adrenal (HPA) axis in rats. Endocr. Regul. 32:1998;77-85.
94. Prevot V., Bouret S., Stefano G.B., Beauvillain J. Median eminence nitric oxide signaling. Brain Res., Brain Res. Rev. 34:2000;27-41.
95. Propes M.J., Johnson R.W. Role of corticosterone in the behavioral effects of central interleukin-1β Physiol. Behav. 61:1997;7-13.
96. Quan N., Whiteside M., Herkenham M. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience. 83:1998;281-293.
97. Raab C., Weidmann E., Schmidt A., Bergmann L., Badenhoop K., Usadel K.H., Haak T. The effects of interleukin-2 treatment on endothelin and the activation of the hypothalamic-pituitary-adrenal axis. Clin. Endocrinol. (Oxf.). 50:1999;37-44.
98. Raber J., Sorg O., Horn T.F., Yu N., Koob G.F., Campbell I.L., Bloom F.E. Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function. Brain Res., Brain Res. Rev. 26:1998;320-326.
99. Rivest S. Molecular mechanisms and neural pathways mediating the influence of interleukin-1 on the activity of neuroendocrine CRF motoneurons in the rat. Int. J. Dev. Neurosci. 13:1995;135-146.
100. Rivier C. Role of endotoxin and interleukin-1 in modulating ACTH, LH and sex steroid secretion. Adv. Exp. Med. Biol. 274:1990;295-301.
101. Rivier C. Stimulatory effect of interleukin-1β on the hypothalamic-pituitary-adrenal axis of the rat: influence of age, gender and circulating sex steroids. J. Endocrinol. 140:1994;365-372.
102. Rivier C. Role of nitric oxide and carbon monoxide in modulating the ACTH response to immune and non-immune signals. Neuroimmunomodulation. 5:1998;203-213.
103. Rivier C. Role of gaseous neurotransmitters in the hypothalamic-pituitary-adrenal axis. Ann. N.Y. Acad. Sci. 933:2001;254-264.
104. Rivier C. Role of nitric oxide and carbon monoxide in modulating the activity of the rodent hypothalamic-pituitary-adrenal axis. Front. Horm. Res. 29:2002;15-49.
105. Rivier C., Shen G.H. In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1β, vasopressin and oxytocin. J. Neurosci. 14:1994;1985-1993.
106. Rivier C., Vale W. Stimulatory effect of interleukin-1 on adrenocorticotropin secretion in the rat: is it modulated by prostaglandins? Endocrinology. 129:1991;384-388.
107. Rivier C., Chizzonite R., Vale W. In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology. 125:1989;2800-2805.
108. Rouveix B. Clinical pharmacology of cytokines. Eur. Cytokine Netw. 8:1997;291-293.
109. Roy A., Berrettini W., DeJong J., Adinoff B., Ravitz B., Linnoila M. CSF neuropeptide Y in alcoholics and normal controls. Psychiatry Res. 33:1990;215-219.
110. Saadé N.E., Abou Jaoude P.G., Saadeh F.A., Hamoui S., Safieh-Garabedian B., Kanaan S.A., Atweh S.F., Jabbur S.J. Fos-like immunoreactivity induced by intraplantar injection of endotoxin and its reduction by morphine. Brain Res. 769:1997;57-65.
111. Saadé N.E., Major S.C., Jabbur S.J., Atweh S.F., Kanaan S.A., Safieh-Garabedian B. Involvement of capsaicin sensitive primary afferents in thymulin-induced hyperalgesia. J. Neuroimmunol. 91:1998;171-179.
112. Saadé N.E., Kafrouni A.I., Saab C.Y., Atweh S.F., Jabbur S.J. Chronic thalamotomy increases pain-related behavior in rats. Pain. 83:1999;401-409.
113. Safieh-Garabedian B., Jalakhian R.H., Saadé N.E., Haddad J.J., Jabbur S.J., Kanaan S.A. Thymulin reduces hyperalgesia induced by peripheral endotoxin injection in rats and mice. Brain Res. 717:1996;179-183.
114. 2. J. Neuroimmunol. 73:1997;162-168.
115. 2 in endotoxin-induced localized inflammatory hyperalgesia. Br. J. Pharmacol. 121:1997;1619-1626.
116. Safieh-Garabedian B., Kanaan S.A., Jabbur S.J., Saadé N.E. Cytokine-mediated or direct effects of thymulin on the nervous system as assessed by pain-related behavior. Neuroimmunomodulation. 6:1999;39-44.
117. Safieh-Garabedian B., Poole S., Haddad J.J., Massaad C.A., Jabbur S.J., Saadé N.E. The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology. 42:2002;864-872.
118. Safieh-Garabedian B., Dardenne M., Pleau J.M., Saadé N.E. Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat. Br. J. Pharmacol. 136:2002;947-955.
119. Schobitz B., Sutanto W., Carey M.P., Holsboer F., de Kloet E.R. Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology. 60:1994;124-133.
120. Shan J., Krukoff T.L. Intracerebroventricular adrenomedullin stimulates the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system and production of hypothalamic nitric oxide. J. Neuroendocrinol. 13:2001;975-984.
121. Smith E.M., Cadet P., Stefano G.B., Opp M.R., Hughes T.K. Jr. IL-10 as a mediator in the HPA axis and brain. J. Neuroimmunol. 100:1999;140-148.
122. Spangelo B.L., Judd A.M., Call G.B., Zumwalt J., Gorospe W.C. Role of the cytokines in the hypothalamic-pituitary-adrenal and gonadal axes. Neuroimmunomodulation. 2:1995;299-312.
123. Stenzel-Poore M., Vale W.W., Rivier C. Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 132:1993;1313-1318.
124. 2 release. Am. J. Physiol. 268:1995;G404-G409.
125. Takao T., Nakata H., Tojo C., Kurokawa H., Nishioka T., Hashimoto K., De Souza E.B. Regulation of interleukin-1 receptors and hypothalamic-pituitary-adrenal axis by lipopolysaccharide treatment in the mouse. Brain Res. 649:1994;265-270.
126. Tsuchiya T., Kishimoto J., Koyama J., Ozawa T. Modulatory effect of L-NAME, a specific nitric oxide synthase (NOS) inhibitor, on stress-induced changes in plasma adrenocorticotropic hormone (ACTH) and corticosterone levels in rats: physiological significance of stress-induced NOS activation in hypothalamic-pituitary-adrenal axis. Brain Res. 776:1997;68-74.
127. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79:1999;1-71.
128. Uehara A., Gottschall P.E., Dahl R.R., Arimura A. Stimulation of ACTH release by human interleukin-1β, but not by interleukin-1α, in conscious, freely moving rats. Biochem. Biophys. Res. Commun. 146:1987;1286-1290.
129. Uehara A., Gottschall P.E., Dahl R.R., Arimura A. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous corticotropin releasing factor. Endocrinology. 121:1987;1580-1582.
130. van der Meer M.J., Sweep C.G., Rijnkels C.E., Pesman G.J., Tilders F.J., Kloppenborg P.W., Hermus A.R. Acute stimulation of the hypothalamic-pituitary-adrenal axis by IL-1β, TNF-α and IL-6: a dose response study. J. Endocrinol. Investig. 19:1996;175-182.
131. van Leeuwen H.J., van der Bruggen T., van Asbeck B.S., Boereboom F.T. Effect of corticosteroids on nuclear factor-κB activation and hemodynamics in late septic shock. Crit. Care Med. 29:2001;1074-1077.
132. Verhoef C.M., van Roon J.A., Vianen M.E., Lafeber F.P., Bijlsma J.W. The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon-γ and interleukin 4 production. Ann. Rheum. Dis. 58:1999;49-54.
133. Weber M.M., Michl P., Auernhammer C.J., Engelhardt D. Interleukin-3 and interleukin-6 stimulate cortisol secretion from adult human adrenocortical cells. Endocrinology. 138:1997;2207-2210.
134. Wissink S., Meijer O., Pearce D., van Der Burg B., van Der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 275:2000;1321-1326.
135. Woiciechowsky C., Schoning B., Daberkow N., Asche K., Stoltenburg G., Lanksch W.R., Volk H.D. Brain-IL-1β induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Brain Res. 816:1999;563-571.
136. Xu Y., Day T.A., Buller K.M. The central amygdala modulates hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β administration. Neuroscience. 94:1999;175-183.
137. Zelazowski P., Patchev V.K., Zelazowska E.B., Chrousos G.P., Gold P.W., Sternberg E.M. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin-1β and α-MSH: studies in rats with different susceptibility to inflammatory disease. Brain Res. 631:1993;22-26.
138. Zhou D., Shanks N., Riechman S.E., Liang R., Kusnecov A.W., Rabin B.S. Interleukin 6 modulates interleukin-1- and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology. 63:1996;227-236.